HNRNPA0

HNRNPA0 is a nuclear RNA-binding protein that controls gene expression post-transcriptionally by binding AU-rich elements (AREs) in target mRNA 3'-UTRs and dictating transcript stability (PMID:24532040). Through ARE-dependent regulation it biases hematopoietic differentiation, with loss disproportionately affecting AU-rich transcripts and shifting myeloid fate from monocytic toward granulocytic (PMID:24532040). Its destabilizing activity is direct and sequence-specific: hnRNPA0 binds the CCR2 3'-UTR and shortens CCR2 mRNA half-life, an effect abolished by mutation or CRISPR deletion of the binding region (PMID:40909274). The protein's output is reprogrammed by lncRNA scaffolding and phosphorylation—the lncRNA LHFPL3-AS2 binds hnRNPA0 and enhances its association with the kinase MAPKAP-K2 (MK2), driving phosphorylation at serine 84, after which hnRNPA0 stabilizes rather than degrades oncogenic transcripts such as BMP7 (PMID:41707979). hnRNPA0 also engages lncRNAs through its RRM2 domain, binding the enhancer lncRNA MY34UE-AS to promote MYB expression and leukemia cell proliferation (PMID:38865811). Beyond endogenous mRNAs, hnRNPA0 restricts HIV-1 by reducing Tat-driven LTR transcription, retaining unspliced viral mRNA in the nucleus, and impairing programmed ribosomal frameshifting (PMID:38899932), and it is targeted by influenza B virus NS1 via its GRD domain (PMID:41817792). Together these findings define hnRNPA0 as a context-dependent ARE/lncRNA-binding regulator whose stabilizing versus destabilizing behavior is set by its protein and RNA partners.

1. 2014 Medium

   Established hnRNPA0 as an ARE-binding regulator of mRNA stability with a defined developmental consequence, linking its molecular activity to myeloid cell fate.

   Evidence RNAi knockdown in primary murine hematopoietic cells with genome-wide microarray profiling

   PMID:24532040

   Open questions at the time

   • Specific ARE-containing transcripts driving the fate shift not individually validated
   • No direct binding site mapping on endogenous targets
   • Stabilizing vs destabilizing mode not resolved here
2. 2024 Medium

   Demonstrated hnRNPA0 acts as an HIV-1 restriction factor through several distinct steps of the viral life cycle, extending its role from mRNA stability to transcription, export, and translational recoding.

   Evidence Knockdown/overexpression in THP-1 and Jurkat cells with LTR reporter, mRNA fractionation, and ribosomal frameshifting assays

   PMID:38899932

   Open questions at the time

   • Direct RNA target/binding sites on HIV-1 transcripts not mapped
   • Mechanism linking nuclear retention to frameshifting effect unclear
   • Whether endogenous hnRNPA0 levels matter in physiological infection untested
3. 2024 Medium

   Identified RRM2 as the lncRNA-binding module and connected hnRNPA0–lncRNA interaction to transcription factor (MYB) induction and leukemia cell growth.

   Evidence RNA pulldown, RIP, domain mapping, and overexpression/knockdown with functional rescue in K562 cells

   PMID:38865811

   Open questions at the time

   • Mechanism by which the lncRNA interaction upregulates MYB not defined
   • Whether RRM2 lncRNA binding competes with ARE-mRNA binding unknown
4. 2025 Medium

   Provided direct genetic evidence that hnRNPA0 destabilizes a specific endogenous mRNA via its 3'-UTR, confirming a causal destabilizing mechanism.

   Evidence Direct binding assay, CRISPR-Cas9 3'-UTR deletion, α-amanitin stability assay, and fractionation in CD4+ T cells and macrophages

   PMID:40909274

   Open questions at the time

   • Decay machinery recruited by hnRNPA0 not identified
   • Generality across other ARE targets not established
5. 2025 Low

   Placed HNRNPA0 in a miRNA-controlled circuit affecting p53/ferroptosis and adipogenesis, broadening its functional reach to lipid metabolism.

   Evidence miR-424-3p overexpression/inhibition with HNRNPA0 rescue, lipidomics, and ROS/GSH measurement in 3T3-L1 cells

   PMID:41381030

   Open questions at the time

   • No direct validation of miR-424-3p binding site on HNRNPA0
   • Mechanistic link between hnRNPA0 and p53/SLC7A11/GPX4 not defined
   • Single study, single cell model
6. 2026 Medium

   Resolved how hnRNPA0 activity is switched toward transcript stabilization, showing a lncRNA scaffold promotes MK2-mediated Ser84 phosphorylation that licenses binding and stabilization of oncogenic mRNAs.

   Evidence RNA-protein binding assay, Co-IP mapping of hnRNPA0–MK2, Ser84 phosphorylation assay, and mRNA stability assessment in ESCC cells

   PMID:41707979

   Open questions at the time

   • Structural basis for phosphorylation-dependent binding switch unknown
   • Whether the same residue governs destabilizing vs stabilizing behavior across targets untested
   • Single lab, single tumor context
7. 2026 Medium

   Mapped a physical interface between influenza B NS1 and hnRNPA0, identifying the GRD domain as a viral hijacking site.

   Evidence Pull-down/LC-MS/MS, Co-IP, immunofluorescence, and BiFC with domain mapping

   PMID:41817792

   Open questions at the time

   • Functional consequence of the NS1–hnRNPA0 interaction for viral replication not established
   • Effect on hnRNPA0 RNA-binding activity unknown

• How hnRNPA0 chooses between destabilizing and stabilizing fates for ARE-containing transcripts, and the genome-wide direct binding landscape, remain unresolved.
• No reported eCLIP/iCLIP direct binding atlas for hnRNPA0 itself
• Decay vs stabilization decision logic uncharacterized
• No structural model of RRM/GRD domain function